HALO logo

Halozyme Therapeutics (HALO) Total debt

Annual Total Debt:

$1.51B+$6.55M(+0.44%)
December 31, 2024

Summary

  • As of today (June 22, 2025), HALO annual total debt is $1.51 billion, with the most recent change of +$6.55 million (+0.44%) on December 31, 2024.
  • During the last 3 years, HALO annual total debt has risen by +$629.12 million (+71.76%).
  • HALO annual total debt is now -0.02% below its all-time high of $1.51 billion, reached on December 31, 2022.

Performance

HALO Total debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherHALObalance sheet metrics

Quarterly Total Debt:

$1.51B+$1.65M(+0.11%)
March 31, 2025

Summary

  • As of today (June 22, 2025), HALO quarterly total debt is $1.51 billion, with the most recent change of +$1.65 million (+0.11%) on March 31, 2025.
  • Over the past year, HALO quarterly total debt has increased by +$6.57 million (+0.44%).
  • HALO quarterly total debt is now at all-time high.

Performance

HALO Quarterly Total Debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherHALObalance sheet metrics

Total debt Formula

Total Debt = Short Term Debt + Long Term Debt

HALO Total debt Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+0.4%+0.4%
3 y3 years+71.8%+71.8%
5 y5 years+274.0%+287.1%

HALO Total debt Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-0.0%+71.8%at high+71.8%
5 y5-year-0.0%+279.1%at high+287.1%
alltimeall time-0.0%>+9999.0%at high>+9999.0%

HALO Total debt History

DateAnnualQuarterly
Mar 2025
-
$1.51B(+0.1%)
Dec 2024
$1.51B(+0.4%)
$1.51B(+0.1%)
Sep 2024
-
$1.50B(+0.1%)
Jun 2024
-
$1.50B(+0.1%)
Mar 2024
-
$1.50B(+0.1%)
Dec 2023
$1.50B(-0.5%)
$1.50B(+0.1%)
Sep 2023
-
$1.50B(+0.1%)
Jun 2023
-
$1.50B(+0.1%)
Mar 2023
-
$1.49B(-0.8%)
Dec 2022
$1.51B(+71.8%)
$1.51B(+0.1%)
Sep 2022
-
$1.50B(+20.7%)
Jun 2022
-
$1.25B(+42.0%)
Mar 2022
-
$877.64M(+0.1%)
Dec 2021
$876.67M(+120.7%)
$876.67M(+0.1%)
Sep 2021
-
$875.71M(+0.1%)
Jun 2021
-
$874.74M(+0.1%)
Mar 2021
-
$873.77M(+120.0%)
Dec 2020
$397.23M(-1.3%)
$397.23M(+0.9%)
Sep 2020
-
$393.63M(+0.9%)
Jun 2020
-
$390.08M(+0.2%)
Mar 2020
-
$389.43M(-3.3%)
Dec 2019
$402.59M(+218.6%)
$402.59M(+530.6%)
Sep 2019
-
$63.84M(-24.9%)
Jun 2019
-
$84.96M(-19.4%)
Mar 2019
-
$105.41M(-16.6%)
Dec 2018
$126.38M(-37.5%)
$126.38M(-13.7%)
Sep 2018
-
$146.46M(-11.8%)
Jun 2018
-
$166.04M(-10.3%)
Mar 2018
-
$185.16M(-8.5%)
Dec 2017
$202.35M(-6.6%)
$202.35M(-2.2%)
Sep 2017
-
$206.85M(-2.0%)
Jun 2017
-
$211.03M(-1.4%)
Mar 2017
-
$214.03M(-1.2%)
Dec 2016
$216.62M(+334.7%)
$216.62M(+2.1%)
Sep 2016
-
$212.20M(+2.0%)
Jun 2016
-
$208.14M(+6.2%)
Mar 2016
-
$196.02M(+293.3%)
Dec 2015
$49.83M(-0.1%)
$49.83M(+0.1%)
Sep 2015
-
$49.79M(+0.1%)
Jun 2015
-
$49.75M(+0.1%)
Mar 2015
-
$49.72M(-0.3%)
Dec 2014
$49.86M(+0.2%)
$49.86M(+0.0%)
Sep 2014
-
$49.84M(+0.0%)
Jun 2014
-
$49.82M(+0.0%)
Mar 2014
-
$49.79M(+0.0%)
Dec 2013
$49.77M
$49.77M(+54.1%)
Sep 2013
-
$32.30M(+1.5%)
DateAnnualQuarterly
Jun 2013
-
$31.82M(+2.2%)
Mar 2013
-
$31.14M(+0.1%)
Dec 2012
$31.11M(>+9900.0%)
$31.11M(>+9900.0%)
Sep 2012
-
$0.00(0.0%)
Jun 2012
-
$0.00(0.0%)
Mar 2012
-
$0.00(0.0%)
Dec 2011
$0.00(0.0%)
$0.00(0.0%)
Sep 2011
-
$0.00(0.0%)
Jun 2011
-
$0.00(0.0%)
Mar 2011
-
$0.00(0.0%)
Dec 2010
$0.00(0.0%)
$0.00(0.0%)
Sep 2010
-
$0.00(0.0%)
Jun 2010
-
$0.00(0.0%)
Mar 2010
-
$0.00(0.0%)
Dec 2009
$0.00(0.0%)
$0.00(0.0%)
Sep 2009
-
$0.00(0.0%)
Jun 2009
-
$0.00(0.0%)
Mar 2009
-
$0.00(0.0%)
Dec 2008
$0.00(0.0%)
$0.00(0.0%)
Sep 2008
-
$0.00(0.0%)
Jun 2008
-
$0.00(0.0%)
Mar 2008
-
$0.00(0.0%)
Dec 2007
$0.00(0.0%)
$0.00(0.0%)
Sep 2007
-
$0.00(0.0%)
Jun 2007
-
$0.00(0.0%)
Mar 2007
-
$0.00(0.0%)
Dec 2006
$0.00(0.0%)
$0.00(0.0%)
Sep 2006
-
$0.00(0.0%)
Jun 2006
-
$0.00(0.0%)
Mar 2006
-
$0.00(0.0%)
Dec 2005
$0.00(0.0%)
$0.00(0.0%)
Sep 2005
-
$0.00(0.0%)
Jun 2005
-
$0.00(0.0%)
Mar 2005
-
$0.00(0.0%)
Dec 2004
$0.00(0.0%)
$0.00(0.0%)
Sep 2004
-
$0.00(0.0%)
Jun 2004
-
$0.00(0.0%)
Mar 2004
-
$0.00(0.0%)
Dec 2003
$0.00(0.0%)
$0.00(0.0%)
Sep 2003
-
$0.00(0.0%)
Jun 2003
-
$0.00(0.0%)
Mar 2003
-
$0.00(0.0%)
Dec 2002
$0.00(0.0%)
$0.00(0.0%)
Sep 2002
-
$0.00(0.0%)
Jun 2002
-
$0.00(0.0%)
Mar 2002
-
$0.00
Dec 2001
$0.00
-

FAQ

  • What is Halozyme Therapeutics annual total debt?
  • What is the all time high annual total debt for Halozyme Therapeutics?
  • What is Halozyme Therapeutics annual total debt year-on-year change?
  • What is Halozyme Therapeutics quarterly total debt?
  • What is the all time high quarterly total debt for Halozyme Therapeutics?
  • What is Halozyme Therapeutics quarterly total debt year-on-year change?

What is Halozyme Therapeutics annual total debt?

The current annual total debt of HALO is $1.51B

What is the all time high annual total debt for Halozyme Therapeutics?

Halozyme Therapeutics all-time high annual total debt is $1.51B

What is Halozyme Therapeutics annual total debt year-on-year change?

Over the past year, HALO annual total debt has changed by +$6.55M (+0.44%)

What is Halozyme Therapeutics quarterly total debt?

The current quarterly total debt of HALO is $1.51B

What is the all time high quarterly total debt for Halozyme Therapeutics?

Halozyme Therapeutics all-time high quarterly total debt is $1.51B

What is Halozyme Therapeutics quarterly total debt year-on-year change?

Over the past year, HALO quarterly total debt has changed by +$6.57M (+0.44%)
On this page